SCHEMBL7408486

SCHEMBL7408486

O=C(O)CCC(NC(=O)C1(C(=O)NC(CC(=O)O)C(=O)CF)CCC1)C(=O)Nc1cccc(Oc2ccccc2)c1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CASP3 P42574 5/20 0.45
MMP2 P08253 2/20 0.41
MMP3 P08254 2/20 0.41
MMP10 P09238 2/20 0.41
MMP9 P14780 2/20 0.41
MMP8 P22894 2/20 0.41
MMP12 P39900 2/20 0.41
MMP13 P45452 2/20 0.41
MMP14 P50281 1/20 0.41
CASP7 P55210 1/20 0.41
CASP9 P55211 1/20 0.41
CASP6 P55212 1/20 0.41
CASP8 Q14790 1/20 0.41
CTNNB1 P35222 7/20 0.40
HDAC2 Q92769 2/20 0.38
HPGD P15428 1/20 0.38
MITF O75030 1/20 0.38
ALDH1A1 P00352 1/20 0.38
POLB P06746 1/20 0.38
MAPK1 P28482 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7410929 0.98 CASP3 (0.45) CASP3MMP2MMP3MMP10MMP9
SCHEMBL7508772 0.97 CASP3 (0.47) CASP3MMP2MMP3MMP10MMP9
SCHEMBL7403799 0.87 CASP3 (0.49) CASP3CASP9CASP6CASP8
SCHEMBL7406759 0.86 MMP2 (0.41) MMP2MMP3MMP10MMP9MMP8
SCHEMBL7408851 0.85 MMP2 (0.41) MMP2MMP3MMP10MMP9MMP8
SCHEMBL7409694 0.83 MMP2 (0.42) MMP2MMP3MMP10MMP9MMP8
SCHEMBL7406574 0.82 CASP3 (0.52) CASP3MMP2MMP3MMP9MMP8
SCHEMBL7404112 0.81 CASP3 (0.48) CASP3CASP6CASP8
SCHEMBL7412017 0.81 CASP3 (0.48) CASP3CASP7CASP9CASP6CASP8
SCHEMBL7408942 0.81 CASP3 (0.49) CASP3CASP9CASP6CASP8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2002076968-A1 MALONATES AS INHIBITORS OF THE ICE/CED-6 FAMILY OF CYSTEINE PROTEASES NOVARTIS AG (CH) 2002-10-03 WO disclosed